Patel Sandip I
Insider CIK 1843601 · AKTX Director · QFTA.U Director · PKBO Director · MTRY Director, 10% owner · ATCH CFO and General Counsel, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKTX Akari Therapeutics Plc | M Exercise deriv | 2026-10-14 | 2026-10-16 | 6,186 | $16.16 | $100.0K | 0 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise deriv | 2026-10-14 | 2026-10-16 | 3,866 | $16.16 | $62.5K | 0 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise | 2026-10-14 | 2026-10-16 | 6,186 | $0.00 | $2 | 38,877 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise | 2026-10-14 | 2026-10-16 | 3,866 | $0.00 | $2 | 32,691 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2026-10-05 | 2026-10-16 | 4,313 | $7.90 | $34.1K | 28,825 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | A Award deriv | 2026-10-01 | 2026-10-02 | 777,332 | — | $0 | 777,332 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | A Award | 2026-09-25 | 2026-09-28 | 50,000 | $0.20 | $10.0K | 905,130 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | P Buy | 2026-09-25 | 2026-09-28 | 50,000 | $0.20 | $10.0K | 905,130 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | P Buy | 2026-09-25 | 2026-09-28 | 50,000 | $0.20 | $9.9K | 905,130 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | A Award | 2026-09-25 | 2026-09-28 | 50,000 | $0.20 | $9.9K | 905,130 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | A Award | 2026-09-24 | 2026-09-28 | 50,000 | $0.22 | $11.0K | 855,130 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | P Buy | 2026-09-24 | 2026-09-28 | 50,000 | $0.22 | $11.0K | 855,130 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | P Buy | 2026-09-24 | 2026-09-28 | 50,000 | $0.22 | $10.9K | 855,130 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | A Award | 2026-09-24 | 2026-09-28 | 50,000 | $0.22 | $10.9K | 855,130 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-08-18 | 2026-10-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-08-18 | 2026-10-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2026-08-18 | 2026-10-16 | 12,100 | $7.90 | $95.6K | 24,512 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | A Award deriv | 2026-07-14 | 2026-07-16 | 731,030 | — | $0 | 731,030 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | A Award deriv | 2026-07-14 | 2026-07-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 247,462 | $0.40 | $99.0K | 247,462 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 247,462 | — | $0 | 247,462 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 154,664 | $0.40 | $61.9K | 154,664 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 154,664 | — | $0 | 154,664 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 225,000 | — | $0 | 225,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 175,000 | — | $0 | 175,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-04-29 | 44,642 | $1.12 | $50.0K | 44,642 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-04-29 | 44,642 | $1.12 | $50.0K | 44,642 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-03-06 | 2025-04-29 | 44,642 | $1.12 | $50.0K | 496,499 | SEC↗ |
| PKBO Peak Bio, Inc. | C Conversion deriv | 2024-11-14 | 2024-11-18 | 400,000 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer deriv | 2024-11-14 | 2024-11-18 | 0 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer | 2024-11-14 | 2024-11-18 | 763,316 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer | 2024-11-14 | 2024-11-18 | 47,364 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer | 2024-11-14 | 2024-11-18 | 67,735 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer | 2024-11-14 | 2024-11-18 | 68,891 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | C Conversion | 2024-11-14 | 2024-11-18 | 763,316 | — | $0 | 763,316 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | J Other deriv | 2024-03-20 | 2024-04-16 | 354,088 | — | $0 | 354,088 | SEC↗ |
| ATCH AtlasClear Holdings, Inc. | J Other | 2024-02-09 | 2024-04-16 | 201,860 | — | $0 | 243,194 | SEC↗ |
| QFTA Quantum FinTech Acquisitio | D To issuer | 2024-02-09 | 2024-02-16 | 41,334 | — | $0 | 0 | SEC↗ |
| MTRY Monterey Innovation Acquis | J Other | 2023-03-09 | 2023-03-13 | 75,000 | — | $0 | 1,417,500 | SEC↗ |
| MTRY Monterey Innovation Acquis | S Sale | 2023-03-09 | 2023-03-13 | 570,000 | $0.01 | $5.7K | 1,342,500 | SEC↗ |
| QFTA.U Quantum FinTech Acquisitio | P Buy | 2021-02-05 | 2021-02-09 | 501 | $10.34 | $5.2K | 41,334 | SEC↗ |